Redwire's SpaceMD Reveals Its First Commercial Mission on SpaceX’s Starfall Spacecraft to Scale In-Space Pharmaceutical Development; SpaceMD Plans To Fly 32 PIL-BOXes In 2028 On This Starfall Mission
Space Microgravity Development LLC (SpaceMD), a wholly owned subsidiary of Redwire Corporation (NYSE:RDW) and venture company focused on leveraging the microgravity environment to create dynamic innovations, announced
Redwire's space medicine company just booked its first big commercial mission to test medicines in space, where there's no gravity. This shows the company is moving from planning to actually doing real business work in space.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.